AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Updates in the treatment of CLL from EHA 2024: BTK and BCL2 inhibitor combinations, BTK degraders, and more
VJHemOnc Podcast
Exploring Different Drug Combinations in CLL Treatment with Focus on Toxicity and Efficacy Trade-offs
Exploring the trade-off between toxicity and efficacy when using different combinations of inhibitors in CLL treatment, discussing deep responses with undetectable MRD levels, toxicity issues requiring dose reductions, considerations for triplets versus doublets, and the necessity of awaiting randomized clinical trial data for decisions on triplet therapy.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode